Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.

@article{Naidu2007TransdermalRA,
  title={Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.},
  author={Yogini Naidu and Kallol Ray Chaudhuri},
  journal={Expert opinion on drug delivery},
  year={2007},
  volume={4 2},
  pages={111-8}
}
An important conceptual development to avoid the occurrence of motor dyskinesias in Parkinson's disease is continuous dopaminergic stimulation. Studies in animal models and humans suggest that continuous dopaminergic stimulation could be achieved by the infusions of different dopamine agonists or levodopa, and may significantly reduce the risk of… CONTINUE READING